Wednesday, August 29, 2018 12:39:27 PM
This ASNB patent, proven effective by the lack of infections in the powerwand studies (over 30,000 days of use) has value, imo. But they have no value assigned to it as an asset on the books.
Antimicrobial polyurethane resins and products made therefrom
Patent number: 7772296
Abstract: The present invention provides novel antimicrobial polyurethane compositions having excellent mechanical and biocompatibility properties, and methods to prepare them. The antimicrobial polyurethane compositions include a homogenous distribution of silver ions by incorporating this antimicrobial agent into the composition prior to the complete polymerization of the polyurethane. In preferred embodiments, the silver ion is associated with a carrier, such as zirconium phosphate or soluble glass powder. The present invention also includes components made from the antimicrobial polyurethane compositions, such as medical devices.
(my emphasis)
https://patents.justia.com/assignee/advansource-biomaterials-corporation
Antimicrobial polyurethane resins and products made therefrom
Patent number: 7772296
Abstract: The present invention provides novel antimicrobial polyurethane compositions having excellent mechanical and biocompatibility properties, and methods to prepare them. The antimicrobial polyurethane compositions include a homogenous distribution of silver ions by incorporating this antimicrobial agent into the composition prior to the complete polymerization of the polyurethane. In preferred embodiments, the silver ion is associated with a carrier, such as zirconium phosphate or soluble glass powder. The present invention also includes components made from the antimicrobial polyurethane compositions, such as medical devices.
(my emphasis)
https://patents.justia.com/assignee/advansource-biomaterials-corporation
Recent NORD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 07:42:23 PM
- Nordicus Partners Corporation Corporate Update • GlobeNewswire Inc. • 02/06/2026 04:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 06:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 02:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 06:08:32 PM
- NoviThera has initiated the first efficacy animal studies • GlobeNewswire Inc. • 11/13/2025 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2025 08:05:16 PM
- Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. • GlobeNewswire Inc. • 10/22/2025 01:00:00 PM
- Orocidin develops novel cGMP manufacturing process in collaboration with Syngene • GlobeNewswire Inc. • 10/20/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/14/2025 01:00:24 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 10/14/2025 01:00:23 PM
- Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS • GlobeNewswire Inc. • 10/03/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 01:43:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 10:07:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 06:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 01:38:25 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2025 06:43:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/29/2025 07:21:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 12:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:55:13 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/27/2025 01:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 01:00:36 PM

